By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Opko Health, Inc. 

4400 Biscayne Boulevard

Miami  Florida  33137  U.S.A.
Phone: 305-575-4100 Fax: n/a


Company News
Opko Health (OPK) Announces 4Kscore Abstracts At The 2015 American Urological Association Annual Meeting 5/18/2015 12:09:35 PM
Opko Health (OPK) Announces Publication Of Study Using Kallikrein Biomarkers Of The 4Kscore Test In A Large Community-Based Referral Cohort 5/15/2015 10:39:50 AM
Opko Health (OPK) Announces First Quarter Operating And Financial Results 5/12/2015 10:50:30 AM
Opko Health (OPK) Snaps Up EirGen for $135 Million 5/6/2015 6:58:02 AM
Conversion Right Triggered On Opko Health, Inc. (OPK) 3.0% Convertible Senior Notes 4/2/2015 12:00:32 PM
Opko Health, Inc. (OPK) Release: Phase 3 Data Supporting Rayaldee As A Treatment For Secondary Hyperparathyroidism In Chronic Kidney Disease To Be Presented At NKF 2015 Spring Clinical Meetings 3/27/2015 10:13:35 AM
Opko Health, Inc. (OPK) Receives Accreditation From College of American Pathologists 3/18/2015 10:27:27 AM
Opko Health, Inc. (OPK) Release: Twelve Months Data Supporting Once-Weekly Dosing Of Hgh-CTP In Growth Hormone Deficient Pediatric Population To Be Presented At ENDO 2015 Conference 3/3/2015 10:20:42 AM
Opko Health, Inc. (OPK) To Announce Fourth Quarter And Full Year 2014 Financial Results On February 27, 2015 2/26/2015 12:17:01 PM
Opko Health, Inc. (OPK) Announces Publication Of 20 Year Outcome Study For Lethal Prostate Cancer Using Kallikrein Biomarkers In 4Kscore Test 2/23/2015 11:58:04 AM